logo
Select company
Select metric
-105.78%EBITDA Margin
VS
Market
12
Sector
37
Industry
65
History
71
$ 3.1Close
$ 2.68 - $ 6.09 52-Week Range
Ticker Information

Ticker

LPCN

Company Name

LIPOCINE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LIPOCINE INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LPCN - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -4.45M-105.78%$ 4.21M
3/31/2025$ -5.32M-144.8%$ 3.67M
12/31/2024$ 50.14K0.45%$ 11.2M
9/30/2024$ -4.02M-50.76%$ 7.92M
6/30/2024$ -8.45M-176.1%$ 4.8M
3/31/2024$ -8.94M-189.65%$ 4.71M
12/31/2023$ -16.32M0%$ -2.85M
9/30/2023$ -16.28M0%$ -3.07M
6/30/2023$ -12.04M-21893.42%$ 54.99K
3/31/2023$ -11.12M-2003.69%$ 554.99K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LIPOCINE INC's latest trailing twelve months (TTM) EBITDA % stands at 0%.
  • Over the past 5 years, LIPOCINE INC's average EBITDA % has been -4179.91%.
  • The median EBITDA % for LIPOCINE INC during this period was -125.29%
  • LIPOCINE INC reached its highest EBITDA % over the past 5 years at 25.09%.
  • The lowest EBITDA % recorded by LIPOCINE INC in the same timeframe -31850.69%

LIPOCINE INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
MRKR : MARKER THERAPEUTICS INC -270.18%BOLT : BOLT BIOTHERAPEUTICS INC -1130.93%TRAW : TRAWS PHARMA INC 3028.45%NRXS : NEURAXIS INC -218.34%LGVN : LONGEVERON INC -838.3%XAIR : BEYOND AIR INC -749.56%DYAI : DYADIC INTERNATIONAL INC -123.19%INM : INMED PHARMACEUTICALS INC -146.8%LEXX : LEXARIA BIOSCIENCE CORP -1829.86%INBS : INTELLIGENT BIO SOLUTIONS INC -240.19%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for LIPOCINE INC is calculated as follows: EBITDA [ $ -20.05M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ]

LPCN - EBITDA Margin, Last 5 years

-31850.69%

Minimum

Sep 30, 2021

25.09%

Maximum

Sep 30, 2022

-4179.91%

Average

-125.29%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%